Eledon Pharmaceuticals Inc.

ELDN | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.89

+$0.20 (+7.43%)

At close: Sep 22, 2026, 4:00 PM ET

$2.97

+$0.08 (+2.77%)

After-hours: Sep 22, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $207.64M

Enterprise Value $119.35M

Beta 0.94

Average Volume 1.24M

Shares Outstanding (Diluted) 113.63M

Shares Change YoY 47.27%

Institutional Ownership 37.91%

Exchange NASDAQ

ISIN US28617K1016

Price Performance

Price Change 1M -21.6%

Price Change 3M -31.9%

Price Change 6M -7.9%

Price Change YTD 66.0%

Price Change 1Y 3.5%

Price Change 3Y 122.3%

Price Change 5Y -59.5%

1M CAGR (ann.) -27.1%

1Y CAGR (ann.) 5.5%

5Y CAGR (ann.) -18.6%

All-Time CAGR -45.4%

Valuation

PE Ratio -0.17

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.20

PS Ratio N/A

Forward PS N/A

PB Ratio 6.29

P/FCF Ratio -2.81

P/Adj. FCF Ratio -2.47

P/OCF Ratio -4.14

EV/Sales N/A

EV/EBIT -1.78

EV/EBITDA -1.33

EV/FCF -1.62

Earnings Yield -576.6%

FCF Yield -35.6%

Adj. FCF Yield -40.5%

Financial Health

Net Cash $88.29M

Total Debt $467K

Cash & Short-Term Investments $88.76M

Total Assets $126.09M

Current Ratio 7.90

Quick Ratio 7.90

Debt / Equity Ratio 0.01

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -158.15

Interest Coverage 0.00

Altman Z-Score -3.91

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -13.9%

Returns

Return on Assets -78.2%

Return on Equity -136.4%

Return on Invested Capital -73.8%

Return on Capital Employed -74.0%

Return on Tangible Assets -105.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -65.1%

EPS CAGR 5Y -27.7%

EPS CAGR 10Y 17.6%

FCF CAGR 3Y -30.6%

FCF CAGR 5Y -24.8%

FCF CAGR 10Y -18.6%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y 31.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.20

EPS Growth Est (next Q) -4.8%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $7

Price Target Upside 160.2%

Cash Flow

Operating Cash Flow $-73.86M

Free Cash Flow $-73.86M

Adj. Free Cash Flow $-84.11M

FCF Per Share -$0.65

OCF Per Share -$0.65

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-84.6M

EBITDA $-89.68M

Net Income $-98.56M

EPS (Diluted) -$15.51

Revenue / Employee N/A

Profit / Employee $-2.99M

Employees 33